IgE-Api m4 is useful to identify a particular phenotype of allergy to bee venom.

Abstract Different clinical behaviours have been identified in patients allergic to bee venom. Compound resolved diagnosis could be appropriated to looking for these differences. Objective: to analyse if sIgE-Api m 4 is able to identify a particular kind of allergy to bee venom, and to describe the response to bee venom immunotherapy (bVIT) of patients. Prospective study including 31 patients allergic to bee venom, who were allocated depending on sIgE-Api m4